Dihydroergotamine Mesylate
Brand name: Dihydroergotamine Mesylate
Rank #485 of 500 drugs by total cost
$14.4M
Total Cost
6,855
Total Claims
$14.4M
Total Cost
166
Prescribers
$2,107
Cost per Claim
543
Beneficiaries
7,006
30-Day Fills
$87K
Avg Cost/Provider
41
Avg Claims/Provider
About Dihydroergotamine Mesylate
Dihydroergotamine Mesylate (sold as Dihydroergotamine Mesylate) was prescribed 6,855 times by 166 Medicare Part D providers in 2023, costing the program $14.4M. At $2,107 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology